Friesenstraße 11
24534 Neumünster
Dr. med. Stefan Mahlmann (Chefarzt)
Services search (in the department)
| Illness | Number of cases |
|---|---|
| Chronic renal failure - Chronic kidney disease stage 5 (N18.5) | 176 |
| Malignant neoplasm of bronchus and lung (C34.1) | 82 |
| Acute kidney failure unspecified (N17.93) | 61 |
| Care involving dialysis (Z49.1) | 51 |
| Volume depletion (E86) | 49 |
| Malignant neoplasm of bronchus and lung (C34.3) | 46 |
| Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00) | 37 |
| Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 33 |
| Other disorders of fluid electrolyte and acid-base balance - Hypo-osmolality and hyponatremia (E87.1) | 33 |
| Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0) | 31 |
| Treatment | Number |
|---|---|
| Procedure for dialysing the blood outside the body with removal of the poison over a concentration gradient - dialysis (8-854.2) | 6.304 |
| Blood purification outside the body through a combination of haemofiltration and dialysis (8-855.3) | 949 |
| Blood purification procedure with detoxification through the peritoneum - peritoneal dialysis (8-857.0) | 926 |
| (9-984.7) | 333 |
| (9-984.8) | 274 |
| Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.90) | 248 |
| Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0) | 209 |
| Procedure to detoxify the blood outside the body with forced removal of the poison - haemofiltration (8-853.3) | 171 |
| Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11) | 168 |
| Uniform basic assessment in terminal care (1-774) | 117 |
| No. | Explanation |
|---|---|
| CQ06 | |
| CQ31 | |
| CQ01 |
| Number | Group |
|---|---|
| 177 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 117 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 80 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Lectureships / teaching posts at universities of applied sciences | |
| Student training (clinical traineeship / internship year) | In Zusammenarbeit mit dem Universitätsklinikum Hamburg Eppendorf UKE und dem Universitätsklinikum Schleswig-Holstein - Campus Kiel. |
| Participation in multi-centre Phase I/II studies | Phase II: CIRCULATE (AIO-KRK-0217) Colon-Ca., randomisierte Doppelblindstudie zum Vergleich von Wirksamkeit, Pharmakokinetik, Sicherheit u. Immunogenität zwischen ABP 234+Keytruda® (Pembrolizumab) bei Pat. mit fortgeschrittenem/metastasiertem nicht-plattenepithelialem nicht-kleinzelligem Lungenkrebs |
| Project-related cooperation with colleges and universities | Hochschulstandort Neumünster |
| Editors of scientific journals/textbooks | |
| Initiation and management of uni-centric/multi-centric clinical/scientific studies | |
| Participation in multi-centre phase III/IV studies | Phase III: FIRE-9-PORT/AIO, metastasiertes Kolorektal-Ca., Phase IV: INGA–fortgeschrittenes/metastasiertes Adeno-Ca. Magen, AEG/Ösophagus, FINN-NSCLC,Multizentrische Beobachtungsstudie zur Beurteilung d. Ergebnisse von Durvalumab-basierten Therapien bei hepatobiliären Krebserkrankungen, MMML-Predict |
| Lectureships / teaching posts at colleges and universities | |
| Doctoral supervision |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB10 | Midwife (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB13 | Medical technical assistant for functional diagnostics (MTAF) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB09 | Speech therapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB07 | Surgical technical assistant (m/f) | |
| HB15 | Anaesthesia technical assistant (m/f) | |
| HB19 | Nursing professionals | 65 Ausbildungsplätze |
| HB17 | Auxiliary nurse (m/f) | 25 Ausbildungsplätze |
| HB03 | Physical therapist / physiotherapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK. |
| HB06 | Occupational therapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB05 | Medical technical radiology assistant (MTRA) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB12 | Medical technical laboratory assistant (MTLA) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB16 | Dietician (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
Günter Humpe-Waßmuth
Patientenombudsmann
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-2223
Mail:
ed.kef@aw-epmuh
Tanja Goos
Beschwerdemanagerin
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-2222
Mail:
ed.kef@soog.ajnat
Andrea Vollert
Leitung Stabsstelle Qualitäts- und Risikomanagement
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-1004
Mail:
ed.kef@trellov.aerdna
PD Dr. med. Andrea Pace
Ärztlicher Direktor, Chefarzt Gastroenterologie
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-7041
Mail:
ed.kef@ecap.aerdna
Malte Dobin
Leitung Apotheke / Ansprechpartner Arzneimitteltherapiesicherheit
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-3600
Mail:
ed.kef@nibod.etlam